A systematic review and meta-analysis of the effectiveness and safety of atovaquone - Proguanil (Malarone) for chemoprophylaxis against malaria

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 5, 2007, Pages 929-936

  Nakato, Halima ^a   Vivancos, Roberto ^a   Hunter, Paul R ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Plasmodium falciparum; Randomized controlled trial; Travel; Tropical medicine

Indexed keywords

ANTIMALARIAL AGENT; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE PLUS PROGUANIL; DOXYCYCLINE; MEFLOQUINE; PLACEBO;

CHEMOPROPHYLAXIS; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EMBASE; HUMAN; INFECTION CONTROL; MALARIA; MEDLINE; META ANALYSIS; PATIENT COMPLIANCE; PATIENT SELECTION; PLASMODIUM FALCIPARUM; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCORING SYSTEM; SELF REPORT; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ANTIMALARIALS; ATOVAQUONE; CHLOROGUANIDE; DRUG COMBINATIONS; HUMANS; MALARIA;

EID: 35448944057     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm337     Document Type: Review

References (26)

1. Legros F. Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996-2003. Emerg Infect Dis 2007; 13: 883-8.
2. Spinazzola F, Nicastri E, Vlassi C et al. Imported malaria at Italy's National Institute for Infectious Diseases Lazzaro Spallanzani, 1984-2003. Eur J Clin Microbiol Infect Dis 2007; 26: 175-9.
3. Centre for Disease Control and Prevention. Traveller's Health: Information for Health Care Providers: Prescription Drugs for Malaria - Determine your Patient's risk. National Centre for Infectious Diseases, Division of Global Migration and Quarantine, Department of Health and Human Services, 2006; 1-9.
4. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17: 1-12.
5. StatsDirect Ltd, 2007. http://www.statsdirect.com/ (4 April 2007, date last accessed).
6. Camus D, Djossou F, Schilthuis HJ et al. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: Results of an international, randomized, open-label study. Clin Infect Dis 2004; 38: 1716-23.
7. Hogh B, Clarke PD, Camus D et al. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team. Lancet 2000; 356: 1888-94.
8. Lell B, Luckner D, Ndjave M et al. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children. Lancet 1998; 351: 709-13.
9. Ling J, Baird JK, Fryauff DJ et al. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia. Clin Infect Dis 2002; 35: 825-33.
10. Overbosch D, Schilthuis H, Bienzie U et al. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clin Infect Dis 2001; 33: 1015-21.
11. Shanks GD, Gordon DM, Klotz FW et al. Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria. Clin Infect Dis 1998; 27: 494-9.
12. Soto J, Toledo J, Luzz M et al. Randomized, double-blind, placebo-controlled study of Malarone for malaria prophylaxis in non-immune Colombian soldiers. Am J Trop Med Hyg 2006; 75: 430-3.
13. Sukwa TY, Mulenga M, Chisdaka N et al. A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia. Am J Trop Med Hyg 1999; 60: 521-5.
14. Faucher JF, Binder R, Missinou MA et al. Efficacy of atovaquone/ proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines. Clin Infect Dis 2002; 35: 1147-54.
15. Schlagenhauf P, Tschopp A, Johnson R et al. Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study. BMJ 2003; 327: 1078.
16. Boggild AK, Parise ME, Lewis LS et al. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II). Am J Trop Med Hyg 2007; 76: 208-23.
17. Patel SN, Kain KC. Atovaquone/proguanil for the prophylaxis and treatment of malaria. Expert Rev Anti Infect Ther 2005; 3: 849-61.
18. Barrett PJ, Emmins PD, Clarke PD et al. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: Postal and telephone survey of travellers. BMJ 1996; 313: 525-8.
19. Carme B, Peguet C, Nevez G. Compliance with and tolerance of mefloquine and chloroquine + proguanil malaria chemoprophylaxis in French short-term travellers to sub-Saharan Africa. Trop Med Int Health 1997; 2: 953-6.
20. Durrheim DN, Gammon S, Waner S et. al. Antimalarial prophylaxis-use and adverse events in visitors to the Kruger National Park. S Afr Med J 1999; 89: 170-5.
21. Overbosch D. Post-marketing surveillance: Adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries. J Travel Med 2003; 10 Suppl 1: S16-20; discussion S21-13.
22. Petersen E. The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults. J Travel Med 2003; 10 Suppl 1: S13-5; discussion S21.
23. Emberger M, Lechner AM, Zelger B. Stevens-Johnson syndrome associated with Malarone antimalarial prophylaxis. Clin Infect Dis 2003; 37: E5-7.
24. Grieshaber M, Lammli J, Marcus L. Acute hepatitis and atovaquone/ proguanil. J Travel Med 2005; 12: 289-90.
25. Lobel HO, Bernard KW, Williams SL et al. Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine. Need for a better dosing regimen. JAMA 1991; 265: 361-4.
26. Bryan JP. Cost considerations of malaria chemoprophylaxis including use of primaquine for primary or terminal chemoprophylaxis. Am J Trop Med Hyg 2006; 75: 416-20.